Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03053141 · ClinicalTrials.gov registry record
RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
A clinical trial of Cardiac Arrythmias, sponsored by Boston Scientific Corporation.
- Active
- Registry status
- 100
- Enrollment target
- 7
- Study locations
NCT03053141 is a study of Cardiac Arrythmias that is active but no longer recruiting, run by Boston Scientific Corporation. The registered enrollment target is 100 participants. The trial reports 7 study locations across 7 states.
The verdict
NCT03053141, a study of Cardiac Arrythmias, is active but no longer recruiting, sponsored by Boston Scientific Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 7
- Study locations
Study Summary
The objective of the RHAPSODY study is to evaluate the performance of new software features in subjects undergoing standard of care catheter-based endocardial mapping for atrial or ventricular tachyarrhythmias using a commercial Rhythmia Mapping System. Results from this study will be used to guide development and refinement of new software features that may be implemented in future commercial software releases.
Conditions Studied
Interventions
- DEVICE Rhythmia Mapping System
Study Locations (7)
Alabama
- University of Alabama at Birmingham - Birmingham
Idaho
- St. Lukes Idaho Cardiology Associates - Boise
Massachusetts
- Lahey Clinic, Inc. - Burlington
New Hampshire
- Catholic Medical Center - Manchester
New Jersey
- Valley Hospital - Ridgewood
MI
- Fondazione Centro San Raffaele - Milan
Other
- Centre Hospitalier Princesse Grace - Monaco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-05 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03053141
The ClinicalTrials.gov registry entry for NCT03053141 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Arrythmias appearing as the primary indexed condition, and to 1 intervention - of which Rhythmia Mapping System is the first listed.
NCT03053141 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Alabama, Idaho, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03053141 about?
NCT03053141 is a clinical study titled "RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)". The objective of the RHAPSODY study is to evaluate the performance of new software features in subjects undergoing standard of care catheter-based endocardial mapping for atrial or ventricular tachyarrhythmias using a commercial Rhythmia Mapping System. Results from this study will be used to guide ...
What is the current status of trial NCT03053141?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2016-05. Estimated completion is 2026-12.
What conditions does trial NCT03053141 study?
This clinical trial studies the following conditions: Cardiac Arrythmias.
What interventions are being tested in trial NCT03053141?
The interventions under investigation include: Rhythmia Mapping System (DEVICE).
Who is sponsoring clinical trial NCT03053141?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03053141 being conducted?
This trial has 7 study locations across Alabama, Idaho, Massachusetts, New Hampshire, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrythmias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.